The International Waldenstrom’s Macroglobulinemia Foundation (IWMF)
The International Waldenstrom’s Macroglobulinemia Foundation ((IWMF) is a patient-founded and patient-driven international nonprofit organization with a simple but compelling vision and mission.
OUR VISION: A world without WM (Waldenstrom’s macroglobulinemia)
OUR MISSION: Support and educate everyone affected by Waldenstrom’s macroglobulinemia (WM) while advancing the search for a cure. The IWMF is committed to creating a world without WM by finding a cure. Since 1999, the IWMF has invested over $20 million in WM research projects throughout the world. Thanks to this research WM patients have better treatment options that can lead to deeper, longer lasting remissions, and fewer side effects.
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
Patient Worthy Posts on Waldenstrom Macroglobulinemia
Making a Major Impact on B Cell Cancers
Accutar Biotechnology, Cranbury, New Jersey recently announced via BioSpace that dosing has begun with the first patient enrolled in the Phase 1 trial of
Combo Treatment Improved Response for Patients with Waldenstrom Macroglobulinemia (WM)
Right now, there are a number of therapeutic options for people living with Waldenstrom macroglobulinemia (WM), such as chemotherapy, immunotherapy, radiation, plasmapheresis, stem cell transplantation,
This May Be the First Published Report on Waldenstrom Macroglobulinemia in Latin America
Waldenstrom macroglobulinemia (WM) is defined as a B-cell lymphoplasmacytic lymphoma. Data from patients in Latin America on WM are scarce. Researchers are hoping to
BTK Inhibitors for Waldenström’s Macroglobulinemia: Comparisons, Benefits, and the Future
According to a story from AJMC, a recent critical review evaluated the class of therapies known as Bruton tyrosine kinase (BTK) inhibitors and their use
First Patient Dosed in MB-106 Trial for NHL, CLL
At the start of October 2022, biopharmaceutical company Mustang Bio, Inc. shared via news release that the first patient was treated in a study
September is Blood Cancer Awareness Month!
An unsettling fact: every three minutes, someone in the United States is diagnosed with some form of blood cancer. September is Blood Cancer Awareness
